Also, using immunohistochemical analysis, Krump et al. observed that the prevalence of CD44+ cells was significantly different in the group of patients with tongue cancer (0%) compared to the group with floor of the mouth cancer (85%) and the other groups (100%) [30]. This evidence concerns the gene CD44 and malignant tumor of floor of mouth.